From: Critical illness gastrointestinal hypomobility disorder and success of enteral erythromycin
Dosage (mg, twice daily) | Percentage of patients | Response rate (%) | Average days | Outcome (%) |
---|---|---|---|---|
125 | 45 | 100 | 4 | 71 |
250 | 37 | 97.5 | 9 | 55 |
500 | 13 | 85.6 | 12 | 43 |
1,000 | 5 | 40 | 11 | 0 |